ArticleJAMA oncology2018

Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer.

Antoine Adenis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.